Acknowledging that its newly selected partner isn't exactly a household name, Amit Munshi, president and CEO of Epirus Biopharmaceuticals Inc., nevertheless expressed full confidence in Poland's Polpharma Group in a profit-sharing collaboration designed to commercialize biosimilars developed by Epirus across a broad swath of territories.